JFIN vs. BSX
JFIN (Jiayin Group Inc.) and BSX (Boston Scientific Corporation) are both stocks. JFIN operates in Internet Content & Information (Communication Services), while BSX operates in Medical Devices (Healthcare). Over the past 5 years, JFIN returned 0.44%/yr vs 0.25%/yr for BSX. At a 0.10 correlation, their price movements are largely independent.
Performance
JFIN vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JFIN achieves a -31.38% return, which is significantly higher than BSX's -53.51% return.
JFIN
- 1D
- -0.75%
- 1M
- 0.00%
- YTD
- -31.38%
- 6M
- -40.33%
- 1Y
- -73.68%
- 3Y*
- -2.93%
- 5Y*
- 0.44%
- 10Y*
- —
BSX
- 1D
- -2.12%
- 1M
- -23.28%
- YTD
- -53.51%
- 6M
- -54.03%
- 1Y
- -56.24%
- 3Y*
- -6.35%
- 5Y*
- 0.25%
- 10Y*
- 7.08%
JFIN vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
JFIN Jiayin Group Inc. | -31.38% | -4.67% | 41.43% | 152.71% | 4.55% | -27.87% | -42.02% | -52.18% |
BSX Boston Scientific Corporation | -53.51% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 21.99% |
Correlation
The correlation between JFIN and BSX is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since May 10, 2019 | 0.10 |
Fundamentals
JFIN:
$205.14M
BSX:
$66.27B
JFIN:
CN¥29.59
BSX:
$2.38
JFIN:
0.91
BSX:
18.65
JFIN:
0.06
BSX:
0.42
JFIN:
0.23
BSX:
3.21
JFIN:
0.31
BSX:
2.56
JFIN:
CN¥6.21B
BSX:
$20.62B
JFIN:
CN¥4.98B
BSX:
$14.52B
JFIN:
CN¥1.80B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JFIN vs. BSX — Risk / Return Rank
JFIN
BSX
JFIN vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jiayin Group Inc. (JFIN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JFIN | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.20 | ||
| Sortino ratioReturn per unit of downside risk | -0.41 | ||
| Omega ratioGain probability vs. loss probability | 0.69 | 0.64 | +0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.94 | -0.96 | +0.01 |
| Martin ratioReturn relative to average drawdown | -1.31 | -2.05 | +0.74 |
Loading charts...
Drawdowns
JFIN vs. BSX - Drawdown Comparison
The maximum JFIN drawdown since its inception was -92.53%, roughly equal to the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for JFIN and BSX.
Loading charts...
Drawdown Indicators
| JFIN | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.53% | -89.15% | -3.38% |
Max Drawdown (1Y)Largest decline over 1 year | -78.35% | -59.01% | -19.34% |
Max Drawdown (3Y)Largest decline over 3 years | -78.74% | -59.01% | -19.73% |
Max Drawdown (5Y)Largest decline over 5 years | -78.74% | -59.01% | -19.73% |
Max Drawdown (10Y)Largest decline over 10 years | — | -59.01% | — |
Current DrawdownCurrent decline from peak | -77.96% | -59.01% | -18.95% |
Average DrawdownAverage peak-to-trough decline | -69.64% | -38.77% | -30.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 56.38% | 27.47% | +28.91% |
Volatility
JFIN vs. BSX - Volatility Comparison
Jiayin Group Inc. (JFIN) has a higher volatility of 17.28% compared to Boston Scientific Corporation (BSX) at 14.47%. This indicates that JFIN's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JFIN | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.28% | 14.47% | +2.81% |
Volatility (6M)Calculated over the trailing 6-month period | 38.23% | 32.98% | +5.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.29% | 35.03% | +17.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 71.42% | 25.78% | +45.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 116.39% | 27.34% | +89.05% |
Dividends
JFIN vs. BSX - Dividend Comparison
JFIN's dividend yield for the trailing twelve months is around 20.10%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% |
JFIN Jiayin Group Inc. | 20.10% | 13.79% | 14.13% | 15.06% |
Financials
JFIN vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Jiayin Group Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JFIN vs. BSX - Profitability Comparison
JFIN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Jiayin Group Inc. reported a gross profit of 751.50M and revenue of 1.08B. Therefore, the gross margin over that period was 69.9%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
JFIN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Jiayin Group Inc. reported an operating income of 93.34M and revenue of 1.08B, resulting in an operating margin of 8.7%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
JFIN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Jiayin Group Inc. reported a net income of 99.24M and revenue of 1.08B, resulting in a net margin of 9.2%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
JFIN and BSX have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JFIN has higher volatility (17.28%) compared to BSX (14.47%). In terms of maximum drawdown, JFIN dropped -92.53% vs BSX's -89.15%.
JFIN currently has the higher Sharpe Ratio (-1.41 vs -1.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JFIN and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer